Printer Friendly

Apomyx Inc. Appoints Seed Industry Leader As CEO.

Business Editors/Health & Medical Writers

BIOWIRE2K

NOTE TO MEDIA: Photo is available in a Smart News Release(TM) on

Business Wire's Home Page at www.businesswire.com and at

www.newstream.com

NORTH LOGAN, Utah--(BW HealthWire)--May 21, 2001

Apomyx Inc. Monday announced the appointment of Kent Schulze, a seed industry leader, as its new chief executive officer.

Schulze, age 57, joined Apomyx on May 15, 2001. Schulze has served in senior management positions in the agricultural seed industry for over 30 years, including top leadership at three global-leading seed companies: DEKALB-PFIZER GENETICS (president/chief operating officer), now part of Monsanto Co. (NYSE: MON), Northrup King Co. (president and CEO), now part of Syngenta AG (NYSE: SYT), and AgriBioTech Inc. (president/COO).

Schulze is also the co-founder of ACCESS Plant Technology Inc., a technology transfer company. In his senior leadership roles he has helped commercialize and implement several now widely used seed industry product and process innovations.

Schulze is well known throughout the seed industry for his leadership and organizational skills, an empowering operational style and for his strategic planning abilities.

In announcing the appointment, Apomyx Chairman and President John Carman said, "Kent Schulze provides the needed commercial seed industry experience and leadership necessary for us to succeed in our goal of conferring perpetual hybridity to crops, equitably and profitably, worldwide."

In commenting on his new challenge, Schulze said, "Apomyx represents a unique opportunity to once again participate in the commercialization of a dynamic new agricultural technology. ApoSync(TM) Technology holds great promise for delivering affordable, value-added products and product improvements, and serving the growing needs of the world's food and fiber markets."

Apomyx Inc. has international pioneer patents (variously allowed and pending) for its ApoSync(TM) technology, which confers, stabilizes and controls apomixis (natural cloning of hybrid plants through their own seed).

The "genetic fixation" of hybrid vigor afforded by apomixis is expected to substantially reduce costs of hybrid seed production for crops currently grown as hybrids. It is also expected to make economical the conversion of varietal crops, e.g. wheat, rice and soybean, to hybrid crops with accompanying yield increases.

Apomyx plans to enter into strategic alliances with seed companies and to develop innovative apomictic seed products for worldwide distribution and sale. Carman, professor of plant genetics, Utah State University, has published research findings concerning apomixis for two decades. Based on his discoveries, he founded Apomyx Inc. on March 2, 1998.

Note: A Photo is available at URL:http://www.businesswire.com/cgi-bin/photo.cgi?pw.052101/bb5
COPYRIGHT 2001 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2001, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:May 21, 2001
Words:422
Previous Article:Twenty Communications Technology Companies to Represent States of Oregon and Washington at SUPERCOMM 2001.
Next Article:Nearly 30 Communications Technology Companies to Represent Canada At SUPERCOMM 2001.


Related Articles
International Accounting Standards Panel Named.
Apomyx Inc.
THIS MONTH IN AGRI MARKETING ...
Syngenta Corporation.
J.C. Robinson Seed Co.
Germination -- The magazine of the Canadian seed industry -- published its first-ever GENEius Edition in January.
This month in Agri Marketing ...

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters